InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Lime Time Free
03/11/24 1:20 PM
profile icon
Lime Time Free
03/05/24 4:43 PM
Bullish
Bullish
profile icon
Lime Time Free
01/09/24 7:36 PM
Bullish
Bullish
profile icon
Renee PremiumMember
02/22/21 9:51 AM
profile icon
rodman PremiumMember
11/03/16 3:27 PM
profile icon
king koopa Free
10/14/15 11:00 PM
profile icon
stock1ace1 Free
10/14/15 10:46 AM
profile icon
scappy Terminated
10/14/15 10:06 AM
profile icon
DarkPool Free
10/14/15 9:53 AM
profile icon
dshade Grandfathered
10/14/15 9:51 AM
profile icon
ccharon86 Free
10/14/15 9:40 AM
profile icon
Caveat Emptor Free
10/14/15 9:34 AM
profile icon
WarMachine Free
03/05/15 9:11 PM
profile icon
Grolden Free
03/05/15 2:21 PM
profile icon
rodman PremiumMember
10/30/14 10:19 AM
profile icon
e-ore PremiumMember
10/30/14 5:52 AM
profile icon
rodman PremiumMember
10/29/14 2:23 PM
profile icon
e-ore PremiumMember
03/26/14 3:16 PM
profile icon
kranthikumar Free
03/26/14 9:51 AM
profile icon
e-ore PremiumMember
11/24/13 3:51 PM
profile icon
ProfitChaser Grandfathered
10/16/13 10:17 PM
profile icon
e-ore PremiumMember
09/02/13 10:04 PM
profile icon
~S.B.A.~ Free
08/22/13 1:32 PM
profile icon
Johnstown Free
08/21/13 12:22 PM
profile icon
e-ore PremiumMember
08/21/13 12:21 PM
profile icon
Johnstown Free
08/21/13 12:17 PM
profile icon
e-ore PremiumMember
08/21/13 11:50 AM
profile icon
~S.B.A.~ Free
08/21/13 9:50 AM
profile icon
~S.B.A.~ Free
08/20/13 12:52 PM
profile icon
e-ore PremiumMember
08/19/13 9:52 PM
profile icon
~S.B.A.~ Free
08/19/13 9:32 PM
profile icon
HokieHead Free
07/23/13 10:23 AM
profile icon
HokieHead Free
07/23/13 10:18 AM
profile icon
HokieHead Free
07/23/13 10:11 AM
profile icon
HokieHead Free
07/23/13 9:52 AM
profile icon
HokieHead Free
07/22/13 1:38 PM
profile icon
HokieHead Free
07/22/13 1:27 PM
profile icon
HokieHead Free
07/22/13 1:21 PM
profile icon
HokieHead Free
07/22/13 1:15 PM
profile icon
alexis62 Free
07/22/13 10:08 AM
profile icon
kranthikumar Free
07/22/13 10:03 AM
profile icon
wizardseye Free
06/07/12 3:21 PM
profile icon
willlbone Free
06/07/12 12:59 PM
profile icon
HokieHead Free
06/06/12 10:18 AM
profile icon
HokieHead Free
06/06/12 9:49 AM

Molecular Pharmacology Ltd (MLPH) RSS Feed

Followers
14
Posters
38
Posts (Today)
0
Posts (Total)
74
Created
07/29/06
Type
Free
Moderators
MOLECULAR PHARMACOLOGY LIMITED


 

Breaking Through the Pain Barrier
COMPANY WEBSITE


COMPANY PROFILE

Molecular Pharmacology (USA) Limited, (MPL-USA) is a public, biotechnology company (OTCBB: MLPH) dedicated to the discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound. MPL-TL, an oligopeptide, is a new key active ingredient that targets a different part of the pain and inflammation cascade than other analgesic/anti-inflammatory drugs. It is the first significant new topical analgesic discovery in nearly 50 years and will drive new products and opportunity in the $36.5 billion analgesia and anti-inflammatory industry. Delivered through the skin, analgesic products based on MPL-TL are expected to be fast acting with localized effects and minimal anticipated drug interactions or side effects .

MPL USA holds the exclusive worldwide rights to develop new and fast-acting analgesic and anti-inflammatory products based on MPL-TL . The parent product for MPL-TL has been used and tested for nearly two decades and has been shown to be fast acting , safe and effective.

MPL's primary objectives are to:
• Refine and bring to clinical trials the first new class of analgesics in several decades.
• Gain American, Australian & European regulatory and marketing approval.
• Manufacture, sell or license MPL-TL as a new, key active ingredient.
MPL-TL100 is the first candidate complex based on MPL-TL. It is currently being tested in human clinical trials for lateral epicondylitis (tennis elbow).

PRODUCTS
(This link goes directly to MLPH's Platform Description)


COMPANY ADDRESS
Drug Discovery Research Centre
284 Oxford Street
Leederville
Perth, WA 6007
Australia
 
MANAGEMENT

Jeff Edwards, Technical Operations Development

Jeff Edwards has over twenty years experience in managing new technological innovations. He is experienced in production, intellectual property, regulatory affairs and quality systems. He is an award winning technology developer in his own right, and has worked across a range of medical and technology fields with organizations including Omni LifeScience, Genesis Biomedical, CollTech Australia, IBM, NCR and Intellect Electronics.

Dr. Maud Eijkenboom

Dr. Eikenboom is a consulting neuroscientist specialising in chronic neuropathic and inflammatory pain. She brings 8 years of expertise managing many of the preclinical studies in animals and clinical development aspects for Bayer Healthcare of Germany. Dr Eikenboom has worked in the Netherlands, Russia, Germany and Brazil and has recently settled in Australia.

Dr. Sal Abdi, Consultant

Dr. Sal Abdi is currently the Chief (LOA) of the Division of Pain Medicine in the Dept. of Anesthesiology, Perioperative Medicine and Pain Management; Professor, Clinical Anesthesiology; Director, Fellowship Program in Pain Medicine; and Medical Director, JMH University of Miami School of Medicine in Miami, Florida and Director of the Massachusetts General Hospital Pain Center Dept. of Anesthesia and Critical Care at MGH; and Assoc. Prof. Anesthesiology (Pending) at Harvard Medical School in Boston, Massachusetts. He is currently licensed in Massachusetts, Texas & Florida.


Dr. Chris Quirk, Dermatology and Clinical Medicine

Dr. Quirk is an Australian dermatologist who has been a teaching hospital consultant for 21 years and has conducted numerous trials for international pharmaceutical companies such as Roche, Novartis, 3M and Matrix and has served on advisory boards for Merck, Allergan and Roche. He has published 22 papers in international journals and most recently has presented at the World Congress of Dermatology in Paris and the World Congress on Cancers of the Skin in Seville.
MARKET ANALYSIS

(This link goes directly to MLPH's Market Analysis Report)

http://www.mpl-usa.com/market_analysis.shtml

RECENT COMPANY NEWS

(This link goes directly to MLPH's News Link)

http://www.mpl-usa.com/press_releases.shtml

 DAILY CHART

SHARE STRUCTURE

Authorized
300,000,000 of common shares, par value $0.001

Issued and outstanding
08 May 2013 - 111,553,740 common shares, par value $0.001
Float 23,550,000

FINANCIALS and SEC FILINGS
(This link goes directly to MLPH's SEC Filings

http://www.sec.gov/cgi-bin/browse-edgar?company=&CIK=mlph&filenum=&State=&SIC=&o....
 
INVESTOR RELATIONS

Investor Relations:
Jeff Edwards
Molecular Pharmacology (USA) Limited
888-327-4122
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
MLPH Latest News
  • No Recent News Available for this company!
New Post